New Key Statistics Module, Z-Score and F-Score
NAS:CLDX Key Ratios
Market Cap $ M | 2,601.49 |
Enterprise Value $ M | 1,821.94 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.10 |
Price/Sales | 328.93 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 6.00 |
EPS (TTM) $ | -2.86 |
Beneish M-Score | -1.84 |
10-y EBITDA Growth Rate % | 24.40 |
5-y EBITDA Growth Rate % | 15.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -12.13 |
EV-to-EBITDA | -12.38 |
PEG | -- |
Shares Outstanding M | 65.91 |
Net Margin (%) | -2,385.97 |
Operating Margin % | -2,473.30 |
Pre-tax Margin (%) | -2,385.97 |
Quick Ratio | 31.77 |
Current Ratio | 31.77 |
ROA % (ttm) | -32.36 |
ROE % (ttm) | -34.58 |
ROIC % (ttm) | -388.92 |
Dividend Yield % | -- |
Altman Z-Score | 50.73 |
CLDX Number of Guru Trades
CLDX Volume of Guru Trades
Gurus Latest Trades with NAS:CLDX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CLDX is held by these investors
Total 2
Celldex Therapeutics Inc Insider Transactions
No Available Data
News about NAS:CLDX
Total 0- 1